Rheumatologists lack guidance on how to manage the reproductive health of their patients, and communication to patients on reproductive health issues is an unmet need. New guidelines from the ACR provide support in the counselling of both female and male patients on the different aspects of their reproductive life.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Sammaritano, L. R. et al. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 72, 529–556 (2020).
Andreoli, L. et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann. Rheum. Dis. 76, 476–485 (2017).
Kim, K. J., Baek, I. W., Park, K. S., Kim, W. U. & Cho, C. S. Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis. Lupus 26, 88–94 (2017).
Tektonidou, M. G. et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann. Rheum. Dis. 78, 1296–1304 (2019).
Lazzaroni, M. G. et al. Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: a multicenter study on 62 pregnancies. Front. Immunol. 10, 1948 (2019).
Götestam Skorpen, C. et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann. Rheum. Dis. 75, 795–810 (2016).
Flint, J. et al. BSR and BHPR standards, guidelines and audit working group. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. Rheumatology (Oxford) 55, 1698–702 (2016).
Flint, J. et al. BSR and BHPR standards, guidelines and audit working group. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford) 55, 693–697 (2016).
Smolen, J. S. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2019-216655 (2020).
Singh, J. A. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 68, 1–26 (2016).
The authors wish to acknowledge the colleagues who have been working enthusiastically in the multidisciplinary Pregnancy Clinic for Autoimmune Rheumatic Diseases at the University Hospital in Brescia and, in particular, the late Dr. David Faden who first started this activity more than 30 years ago.
The authors declare no competing interests.
About this article
Cite this article
Tincani, A., Andreoli, L. A guide to managing reproductive health in rheumatology. Nat Rev Rheumatol 16, 411–412 (2020). https://doi.org/10.1038/s41584-020-0443-z